Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read moreCampaigns and resources that provide weight-related messages may lead to unintended consequences.
Read moreNEDC is dedicated to developing and implementing a nationally consistent, evidence-based system of care for the prevention and treatment of eating disorders.
Read moreNEDC e-Bulletin Issue 37 Editor’s Note Welcome to the thirty-seventh edition of the NEDC e-Bulletin.
Read more